Loading
Total declarations
Companies
▲ Purchases (0 ops.)
▼ Sales (14 ops.)
Latest filing published 03 Jun 2025 for OMNICELL, INC..
Filing timeline
BuySaleKaushik Ghoshal
Insider track record
Disclosed buys
0
Disclosed sells
14
Signal history
Kaushik Ghoshal: trading record in brief
Kaushik Ghoshal, President, SaaS Business at ResMed Inc, has 50 filings published from November 15, 2021 to June 3, 2025, 3 of them at Omnicell, Inc., as a Director. The record stops in spring 2025: no filing falls in the last twelve months.
The 14 sales total EUR 9,290,493, with a median of EUR 311,742. The three largest, all at ResMed Inc, are dated March 10, 2025 (EUR 2,147,282), August 12, 2024 (EUR 1,980,569) and September 12, 2024 (EUR 1,139,930). No purchase is recorded. The record also counts 21 grants, 13 option exercises and 2 filings of another kind.
The volume rises until 2024: 4 filings in 2021, 5 in 2022, 11 in 2023, then 16 in 2024 and 14 in 2025. Filings come out a median of 1 day after the trade, a short delay.
At ResMed Inc, 14 of Ghoshal's trades fall within 30 days of a trade by Michael J. Farrell, 12 of one by Brett Sandercock and by Peter C. Farrell, 9 of one by Michael J. Rider, always in the same direction.
Companies and markets linked to Kaushik Ghoshal
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations50 total
6,401 shares0Common StockSEC:0001415889-25-015380:0
105 shares@ US$211.760.1% of flowResMed Common StockSEC:0001127602-25-009051:1
3,589 shares@ US$146.342.5% of flowResMed Common StockSEC:0001127602-25-009051:2
5,882 shares@ US$211.765.8% of flowResMed Common StockSEC:0001127602-25-009051:3
9,745 shares@ US$239.3110.9% of flowResMed Common StockSEC:0001127602-25-009051:4
169 shares@ US$146.340.5% of flowResMed Common StockSEC:0001127602-25-009051:0
3,506 shares@ US$146.342.5% of flowResMed Common StockSEC:0001127602-25-007977:1
514 shares@ US$146.340.4% of flowResMed Common StockSEC:0001127602-25-007977:2
4,726 shares@ US$211.764.9% of flowResMed Common StockSEC:0001127602-25-007977:3
367 shares@ US$235.250.4% of flowResMed Common StockSEC:0001127602-25-007977:4
3,506 shares@ US$235.404.0% of flowResMed Common StockSEC:0001127602-25-007977:5
514 shares@ US$235.250.6% of flowResMed Common StockSEC:0001127602-25-007977:6
4,726 shares@ US$235.435.4% of flowResMed Common StockSEC:0001127602-25-007977:7
367 shares@ US$211.761.6% of flowResMed Common StockSEC:0001127602-25-007977:0
445.59 shares@ US$252.380.5% of flowResMed Common StockSEC:0001127602-24-027070:1
1,417.93 shares@ US$252.381.7% of flowResMed Common StockSEC:0001127602-24-027070:2
603.075 shares@ US$252.383.0% of flowResMed Common StockSEC:0001127602-24-027070:0
9,628.1 shares0ResMed Common StockSEC:0001127602-24-026257:1
9,628.096 shares0ResMed Common StockSEC:0001127602-24-026257:0
4,260 shares@ US$238.484.7% of flowResMed Common StockSEC:0001127602-24-025433:1
4,260 shares@ US$101.648.3% of flowResMed Common StockSEC:0001127602-24-025433:0
5,000 shares@ US$252.565.8% of flowResMed Common StockSEC:0001127602-24-023884:1
5,000 shares@ US$101.649.6% of flowResMed Common StockSEC:0001127602-24-023884:0
841 shares0ResMed Common StockSEC:0001127602-24-022296:1
7,915 shares0ResMed Common StockSEC:0001127602-24-022296:0
25 of 50 declarations
